Back to results
US 2025/0052765 A1Published application
Nanobody Discovery Platform and Related Methods
AssigneeCarnegie Mellon University
InventorsChristopher S. Szent-Gyorgyi, Robert Van De Weerd, Brigitte F. Schmidt, Marcel P. Bruchez
Life of this patent
Estimating the term…
Abstract
Provided herein are methods, nucleic acids, transformed yeast cells, and kits useful for rapid and effective multiplexed identification of nanobody binding to a target protein domain.
Claims34
A nucleic acid comprising one or more inducible gene for expressing in a yeast cell:
- a first fusion protein comprising amino acid sequences of:
- an anchor peptide selected for anchoring the first fusion protein in a cell wall of the cell, a nanobody, and an scFv (FAP) for binding a first fluorophore;
- and
- a second fusion protein comprising amino acid sequences of a secretion signal peptide and an scFv (FAP) for binding a second fluorophore,
- wherein the first fluorophore increases fluorescent emissions, e.g., at least 1000-fold, at an excitation wavelength when bound by the scFv of the first fusion protein, the second fluorophore increases fluorescent emissions, e.g., at least 1000-fold, at an excitation wavelength when bound by the scFv of the second fusion protein, and the fluorescent emission of the scFv-bound first fluorophore is detectably different from that of the scFv-bound second fluorophore, wherein the nucleic acid further comprises a barcode for identifying a target protein domain (TPD) in the coding sequence of the first fusion protein and wherein the first fusion peptide optionally comprises one or more type IIS restriction endonuclease recognition site-terminated DNA modules.
2 more elements
(canceled)
9-12. (canceled)
14-15. (canceled)
19-20. (canceled)
(canceled)
(canceled)
(canceled)
31-34. (canceled)
(canceled)
38-39. (canceled)
41-42. (canceled)
44-54. (canceled)
Dependencies are inferred from the claim text.